Postpartum Depression Treatment Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032

Postpartum Depression Treatment Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032



Growth Factors of Postpartum Depression Treatment Market

The Postpartum Depression Treatment market size was valued at USD 12.2 million in 2023, and the market is now projected to grow from USD 79.9 million in 2024 to USD 973.0 million by 2032, exhibiting a CAGR of 36.7% during the forecast period of 2024-2032.

The reason behind the slowed down in market growth is that many people do not go for treatment when they give birth because of fear they might be infected with COVID-19. Moreover, the Postpartum Depression Treatment market growth could not be expanded during the pandemic since there were also other factors like lack of diagnosis facilities. Apart from these reasons, there were also some other reasons why there was no growth of the market during this period of time even after approval on postnatal depression medications.

Some HTML & CSS are written in a way that you have to follow certain procedures so that the code can work. This Postpartum Depression Treatment market share adherence to a specific perception of how the language should behave in different contexts means the language has conventions that require certain steps or decisions be made.

Specific patient care tools are increasingly needed as cases of postpartum depression are on the rise. There are now various technologies such as gadgets and techniques which adopt AI and ML technology for better understanding the symptoms as well as treatment options hence management can be enhanced.

Comprehensive Analysis of Postpartum Depression Treatment Market

The Postpartum Depression Treatment market and Healthcare industry Grows rapidly because of the way it is broken down into smaller markets. These segmentations are methodically segregated by Drug Analysis, by Route of Administration Analysis, by Distribution Channel Analysis. The Drug Analysis, brexanolone, zuranolone, and others. However, the Route of Administration Analysis, parenteral, oral, and others. The Distribution Channel Analysis, specialty pharmacies and hospital pharmacies.

The North American region was in charge for making the largest market of the Postpartum Depression Treatment sale of USD 12.2 million in 2023 due to It is expected that the region will be one of the best regions in the market.

The top players in the market play a crucial role in the Healthcare industry prospectus growth and setting market standards. These players include, Biogen Inc. (U.S.), Sage Therapeutics, Inc. (U.S.), GH Research Ireland Limited (Ireland), Brii Biosciences Limited (China), these market players provide a level-playing competitive landscape.

In August 2023, Sage Therapeutics, Inc. and Biogen Inc. have jointly announced the United States Food and Drug Administration’s approval of ZURZUVAE (zuranolone)—the inaugural orally prescribed medication that can immediately alleviate the depression in postpartum women. That judgment serves as a substantial breakthrough when it comes to medical care for PPD by giving swift respite through an easily accessible mode of therapy.

Segmentation Table

ATTRIBUTE DETAILS

Study Period 2019-2032

Base Year 2023

Estimated Year 2024

Forecast Period 2024-2032

Historical Period 2019-2022

Growth Rate CAGR of 36.7% from 2024-2032

Unit Value (USD million)

Segmentation ByDrug

Zuranolone

Brexanolone

Others

ByRoute of Administration

Oral

Parenteral

Others

By Distribution Channel

Hospital Pharmacies

Specialty Pharmacies

By Region

North America (By Drug, Route of Administration, Distribution Channel, and Country/Sub-Region)

- U.S.

- Canada

Asia Pacific (By Drug, Route of Administration, Distribution Channel, and Country/Sub-Region)

- China

- Japan

- India

- Australia

- Rest of the Asia Pacific

Rest of the World ( By Drug, Route of Administration, and Distribution Channel)

Please Note: It will take 5-6 business days to complete the report upon order confirmation.


1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Market Trends
4. Key Insights
4.1. Prevalence of Postpartum Depression - By Key Countries/Regions, 2022/2023
4.2. Pipeline Analysis, By Key Players
4.3. Regulatory and Reimbursement Scenario, By Key Countries/Regions
4.4. Key Industry Developments: Mergers, Acquisitions, and Partnerships
4.5. Impact of COVID-19 on the Global Postpartum Depression Market
5. Global Postpartum Depression Treatment Market Analysis, Insights and Forecast, 2019-2032
5.1. Market Analysis, Insights and Forecast – By Drug
5.1.1. Zuranolone
5.1.2. Brexanolone
5.1.3. Others
5.2. Market Analysis, Insights and Forecast – By Route of Administration
5.2.1. Oral
5.2.2. Parenteral
5.2.3. Others
5.3. Market Analysis, Insights and Forecast – By Distribution Channel
5.3.1. Hospital Pharmacies
5.3.2. Specialty Pharmacies
5.4. Market Analysis, Insights and Forecast – By Region
5.4.1. North America
5.4.2. Asia Pacific
5.4.3. Rest of the World
6. North America Postpartum Depression Treatment Market Analysis, Insights and Forecast, 2019-2032
6.1. Market Analysis, Insights and Forecast – By Drug
6.1.1. Zuranolone
6.1.2. Brexanolone
6.1.3. Others
6.2. Market Analysis, Insights and Forecast – By Route of Administration
6.2.1. Oral
6.2.2. Parenteral
6.2.3. Others
6.3. Market Analysis, Insights and Forecast – By Distribution Channel
6.3.1. Hospital Pharmacies
6.3.2. Specialty Pharmacies
6.4. Market Analysis, Insights and Forecast – By Country
6.4.1. U.S.
6.4.2. Canada
7. Asia Pacific Postpartum Depression Treatment Market Analysis, Insights and Forecast, 2019-2032
7.1. Market Analysis, Insights and Forecast – By Drug
7.1.1. Zuranolone
7.1.2. Brexanolone
7.1.3. Others
7.2. Market Analysis, Insights and Forecast – By Route of Administration
7.2.1. Oral
7.2.2. Parenteral
7.2.3. Others
7.3. Market Analysis, Insights and Forecast – By Distribution Channel
7.3.1. Hospital Pharmacies
7.3.2. Specialty Pharmacies
7.4. Market Analysis, Insights and Forecast – By Country/Sub-region
7.4.1. China
7.4.2. Japan
7.4.3. India
7.4.4. Australia
7.4.5. Rest of Asia Pacific
8. Rest of the World Postpartum Depression Treatment Market Analysis, Insights and Forecast, 2019-2032
8.1. Market Analysis, Insights and Forecast – By Drug
8.1.1. Zuranolone
8.1.2. Brexanolone
8.1.3. Others
8.2. Market Analysis, Insights and Forecast – By Route of Administration
8.2.1. Oral
8.2.2. Parenteral
8.2.3. Others
8.3. Market Analysis, Insights and Forecast – By Distribution Channel
8.3.1. Hospital Pharmacies
8.3.2. Specialty Pharmacies
9. Competitive Analysis
9.1. Global Market Share Analysis (2023)
9.2. Company Profiles
9.2.1. Sage Therapeutics, Inc.
9.2.1.1. Overview
9.2.1.2. Products & Services
9.2.1.3. SWOT Analysis
9.2.1.4. Recent Developments
9.2.1.5. Strategies
9.2.1.6. Financials (Based on Availability)
9.2.2. Biogen Inc.
9.2.2.1. Overview
9.2.2.2. Products & Services
9.2.2.3. SWOT Analysis
9.2.2.4. Recent Developments
9.2.2.5. Strategies
9.2.2.6. Financials (Based on Availability)
9.2.3. Brii Biosciences Limited
9.2.3.1. Overview
9.2.3.2. Products & Services
9.2.3.3. SWOT Analysis
9.2.3.4. Recent Developments
9.2.3.5. Strategies
9.2.3.6. Financials (Based on Availability)
9.2.4. GH Research Ireland Limited
9.2.4.1. Overview
9.2.4.2. Products & Services
9.2.4.3. SWOT Analysis
9.2.4.4. Recent Developments
9.2.4.5. Strategies
9.2.4.6. Financials (Based on Availability)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings